| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8744998 | Clinical Microbiology and Infection | 2017 | 22 Pages |
Abstract
Neonates treated with vancomycin are at a higher risk of LOS caused by vancomycin-nonsusceptible S. capitis. The use of vancomycin in neonates must urgently be optimized to limit the selection of vancomycin-nonsusceptible strains, for which alternative antibiotics are lacking.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. Butin, J.-P. Rasigade, F. Subtil, P. Martins-Simões, C. Pralong, A.-M. Freydière, F. Vandenesch, S. Tigaud, J.-C. Picaud, F. Laurent,